Lumios

Lumios may be available in the countries listed below.

Ingredient matches for Lumios

Tranilast

Tranilast is reported as an ingredient of Lumios in the following countries:

• Japan

International Drug Name Search

Potasio Cloruro

Potasio Cloruro may be available in the countries listed below.

Ingredient matches for Potasio Cloruro

Potassium Chloride

Potassium Chloride is reported as an ingredient of Potasio Cloruro in the following countries:

• Chile

International Drug Name Search

Panos

Panos may be available in the countries listed below.

Ingredient matches for Panos

Tetrazepam

Tetrazepam is reported as an ingredient of Panos in the following countries:

• France

International Drug Name Search

Merin

Merin may be available in the countries listed below.

Ingredient matches for Merin

Domperidone

Domperidone is reported as an ingredient of Merin in the following countries:

• Bangladesh

International Drug Name Search

Buffered Pirin

Buffered Pirin may be available in the countries listed below.

Ingredient matches for Buffered Pirin

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Buffered Pirin in the following countries:

• Israel

International Drug Name Search

Psorex

Psorex may be available in the countries listed below.

Ingredient matches for Psorex

Clobetasol

Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Psorex in the following countries:

• Brazil

International Drug Name Search

Defluina

Defluina may be available in the countries listed below.

Ingredient matches for Defluina

Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Defluina in the following countries:

• Germany

International Drug Name Search

Maxdosa

Maxdosa may be available in the countries listed below.

Ingredient matches for Maxdosa

Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Maxdosa in the following countries:

• Argentina

International Drug Name Search

Meleril

Meleril may be available in the countries listed below.

Ingredient matches for Meleril

Thioridazine

Thioridazine hydrochloride (a derivative of Thioridazine) is reported as an ingredient of Meleril in the following countries:

• Argentina

International Drug Name Search

Ectospasmol

Ectospasmol may be available in the countries listed below.

Ingredient matches for Ectospasmol

Mesalazine

Mesalazine is reported as an ingredient of Ectospasmol in the following countries:

• Greece

International Drug Name Search

Ocella

Generic Name: drospirenone and ethinyl estradiol (Oral route)

droe-SPYE-re-none, ETH-i-nil es-tra-DYE-ol

Oral route(Tablet)

Cigarette smoking increases the risk of serious cardiovascular events from oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. Women who are over 35 years of age and smoke should not use oral contraceptives .

Commonly used brand name(s)

In the U.S.

• Gianvi


• Loryna


• Ocella


• Syeda


• Vestura


• Yasmin


• YAZ


• Yaz 28


• Zarah

Available Dosage Forms:

• Tablet

Therapeutic Class: Monophasic Contraceptive Combination

Pharmacologic Class: Progestin

Uses For Ocella

Drospirenone and ethinyl estradiol combination is used as an oral contraceptive. Oral contraceptives are known also as the Pill, OCs, BCs, BC tablets, or birth control pills. This medicine usually contains two types of hormones, estrogens and progestins and, when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month. The egg can no longer accept a sperm and fertilization is prevented. Although oral contraceptives have other effects that help prevent a pregnancy from occurring, this is the main action.

This medicine is also used to treat premenstrual dysphoric disorder (PMDD). PMDD is a severe form of premenstrual syndrome (PMS). Patients with PMDD may experience severe emotional and physical symptoms 10 to 14 days before their menstrual flow starts .

No contraceptive method is 100 percent effective. Discuss with your health care professional your options for birth control .

Drospirenone and ethinyl estradiol combination is also used to treat acne in women at least 14 years of age, who have already started menstruating and choose to use a birth control pill to prevent pregnancy .

This medicine is available only with your doctor's prescription.

Before Using Ocella

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

This medicine is not intended for use in children or teenagers who have not yet started menstruating. This medicine is frequently used for birth control in teenage females and has not been shown to cause different side effects or problems than it does in adults. Some teenagers may need extra information on the importance of taking this medication exactly as prescribed.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	X	Studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. This drug should not be used in women who are or may become pregnant because the risk clearly outweighs any possible benefit.

Breast Feeding

Drospirenone

Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine.

Ethinyl Estradiol

Studies suggest that this medication may alter milk production or composition. If an alternative to this medication is not prescribed, you should monitor the infant for side effects and adequate milk intake.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Boceprevir

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Boceprevir


• Felbamate


• Isotretinoin


• Paclitaxel


• Paclitaxel Protein-Bound


• Theophylline


• Tizanidine


• Tranexamic Acid

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Alprazolam


• Amoxicillin


• Ampicillin


• Amprenavir


• Aprepitant


• Atazanavir


• Bacampicillin


• Betamethasone


• Bexarotene


• Bosentan


• Carbamazepine


• Colesevelam


• Cyclosporine


• Darunavir


• Delavirdine


• Doxycycline


• Efavirenz


• Etravirine


• Fosamprenavir


• Fosaprepitant


• Fosphenytoin


• Ginseng


• Griseofulvin


• Lamotrigine


• Licorice


• Minocycline


• Modafinil


• Mycophenolate Mofetil


• Mycophenolic Acid


• Nelfinavir


• Nevirapine


• Oxcarbazepine


• Oxytetracycline


• Phenobarbital


• Phenytoin


• Pioglitazone


• Prednisolone


• Primidone


• Rifabutin


• Rifampin


• Rifapentine


• Ritonavir


• Roflumilast


• Rosuvastatin


• Rufinamide


• Selegiline


• St John's Wort


• Telaprevir


• Tetracycline


• Tipranavir


• Topiramate


• Troglitazone


• Troleandomycin


• Valdecoxib


• Voriconazole


• Warfarin

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use this medicine, or give you special instructions about the use of food, alcohol, or tobacco.

• Caffeine


• Grapefruit Juice

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Abnormal changes in menstrual or uterine bleeding or


• Fibroid tumors of the uterus—Oral contraceptives usually improve these female conditions but sometimes they can make them worse or make the diagnosis of these problems more difficult.

• Adrenal insufficiency or


• Liver problems or


• Kidney problems—These conditions may increase the risk of retaining too much potassium in the blood.

• Blood clots (or history of) or


• Heart or circulation disease or


• Stroke (or history of)—If these conditions are already present, oral contraceptives may have a greater chance of causing blood clots or circulation problems, especially in women who smoke tobacco. Otherwise, oral contraceptives may help prevent circulation and heart disease if you are healthy and do not smoke.

• Cancer, including breast cancer (or history of or family history of)—Oral contraceptives may worsen some cancers, especially when breast, cervical, or uterine cancers already exist. Use of oral contraceptives is not recommended if you have any of these conditions. If you have a family history of breast disease, oral contraceptives may still be a good choice but you may need to be tested more often.

• Gallbladder disease or gallstones (or history of) or


• High blood cholesterol or


• High blood potassium or


• Liver disease (or history of, including jaundice during pregnancy) or


• Mental depression (or history of)—Oral contraceptives may make these conditions worse or, rarely, cause them to occur again. Oral contraceptives may still be a good choice but you may need to be tested more often.

• High blood pressure (hypertension) or


• Migraine headaches—Oral contraceptives may cause fluid build-up and may cause these conditions to become worse; however, some people have fewer migraine headaches when they use oral contraceptives.

Proper Use of drospirenone and ethinyl estradiol

This section provides information on the proper use of a number of products that contain drospirenone and ethinyl estradiol. It may not be specific to Ocella. Please read with care.

Make certain your health care professional knows if you are on any special diet, such as a low-sodium or low-sugar diet.

To make using oral contraceptives as safe and reliable as possible, you should understand how and when to take them and what effects may be expected.

A paper with information for the patient will be given to you with your filled prescription, and will provide many details concerning the use of oral contraceptives. Read this paper carefully and ask your health care professional if you need additional information or explanation.

When you begin to use oral contraceptives, your body will require at least 7 days to adjust before a pregnancy will be prevented. You will need to use an additional birth control method for at least 7 days. Some doctors recommend using an additional method of birth control for the first cycle (or 3 weeks) to ensure full protection. Follow the advice of your doctor or other health care professional.

Try to take the doses no more than 24 hours apart to reduce the possibility of side effects and to prevent pregnancy. Since one of the most important factors in the proper use of oral contraceptives is taking every dose exactly on schedule, you should never let your tablet supply run out. When possible, try to keep an extra month's supply of tablets on hand and replace it monthly.

It is very important that you keep the tablets in their original container and take the tablets in the same order that they appear in the container. The containers help you keep track of which tablets to take next. Different colored tablets in the same package contain different amounts of hormones or are placebos (tablets that do not contain hormones). The effectiveness of the medicine is reduced if the tablets are taken out of order.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

Your doctor may ask you to begin your dose on the first day of your menstrual period (called Day 1 start) or on Sunday after your period starts (called Sunday start). When you begin on a certain day it is important that you follow that schedule, even when you miss a dose. Do not change your schedule on your own. If the schedule that you have been put on is not convenient, check with your doctor about changing schedules. For Sunday start you need to use another form of birth control for the first 7 days.

For Yasmin(R) and Yaz(R), begin next and all subsequent 28-day regimens of therapy on the same day of the week as the first regimen began and follow the same schedule .

• For oral dosage form (tablets):
  
  • For contraception or treatment of acne:
    
    • Adults and teenagers (after menarche) — Yasmin(R), 1 yellow tablet by mouth every day for 21 consecutive days followed by 1 white (inert) tablet daily for 7 days per menstrual cycle
    
    
    • Adults and teenagers (after menarche)— Yaz(R), 1 pink tablet by mouth every day for 24 consecutive days followed by 1 white (inert) tablet daily for 4 days per menstrual cycle
    
    
  
  

Missed Dose

Call your doctor or pharmacist for instructions.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Ocella

It is very important that your doctor check your progress at regular visits to make sure this medicine does not cause unwanted effects. These visits will usually be every 6 to 12 months, but some doctors require them more often.

This medicine will not protect you from getting HIV/AIDS or other sexually transmitted diseases. If this is a concern for you, talk with your doctor .

Tell the medical doctor or dentist in charge that you are taking this medicine before any kind of surgery (including dental surgery) or emergency treatment. Your doctor will decide whether you should continue taking this medicine .

Vaginal bleeding of various amounts may occur between your regular menstrual periods during the first 3 months of use. This is sometimes called spotting when slight, or breakthrough bleeding when heavier. If this should occur:

• Continue on your regular dosing schedule.


• The bleeding usually stops within 1 week.


• Check with your doctor if the bleeding continues for more than 1 week.


• After you have been taking oral contraceptives on schedule and for more than 3 months and bleeding continues, check with your doctor.

Missed menstrual periods may occur:

• If you have not taken the medicine exactly as scheduled. Pregnancy must be considered as a possibility.


• If the medicine is not the right strength or type for your needs.


• If you stop taking oral contraceptives, especially if you have taken oral contraceptives for 2 or more years.

Check with your doctor if you miss any menstrual periods so that the cause may be determined.

If you suspect that you may have become pregnant, stop taking this medicine immediately and check with your doctor.

If you are scheduled for any laboratory tests, tell your doctor that you are taking birth control pills.

Check with your doctor before refilling an old prescription, especially after a pregnancy. You will need another physical examination and your doctor may change your prescription.

Check with your doctor immediately if you wear contact lenses or if blurred vision, difficulty in reading, or any other change in vision occurs during or after treatment. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor) .

Ocella Side Effects

Healthy women who do not smoke cigarettes have almost no chance of having a severe side effect from taking oral contraceptives. For most women, more problems occur because of pregnancy than will occur from taking oral contraceptives. But for some women who have special health problems, oral contraceptives can cause some unwanted effects. Some of these unwanted effects include benign (not cancerous) liver tumors, liver cancer, or blood clots or related problems, such as a stroke. Although these effects are very rare, they can be serious enough to cause death. You may want to discuss these effects with your doctor.

Smoking cigarettes during the use of oral contraceptives has been found to greatly increase the chances of these serious side effects occurring. To reduce the risk of serious side effects, do not smoke cigarettes while you are taking oral contraceptives.

Check with your doctor immediately if any of the following side effects occur:

Rare

• Abdominal or stomach pain (sudden, severe, or continuing)


• anxiety


• burning pain in lower abdomen


• changes in skin color


• chill


• convulsions


• coughing up blood


• feeling of heat


• feeling of warmth in lips and tongue


• fever


• headache (severe or sudden)


• loss of coordination (sudden)


• loss of vision or change in vision (sudden)


• nervousness


• numbness of the fingertips


• pain in lower back, pelvis, or stomach


• pains in chest, groin, or leg (especially in calf of leg)


• ringing in the ears


• shortness of breath (sudden or unexplained)


• slurring of speech (sudden)


• sudden loss of consciousness


• swelling of foot or leg


• weakness, numbness, or pain in arm or leg (unexplained)

Check with your doctor as soon as possible if any of the following side effects occur:

More common—usually less common after the first 3 months of oral contraceptive use

• Changes in the uterine bleeding pattern at menses or between menses, such as decreased bleeding at menses, breakthrough bleeding or spotting between periods, prolonged bleeding at menses, complete stopping of menstrual bleeding that occurs over several months in a row, or stopping of menstrual bleeding that only occurs sometimes.

Less common

• Headaches or migraines (although headaches may lessen in many users, in others, they may increase in number or become worse)


• increased blood pressure


• vaginal infection with vaginal itching or irritation, or thick, white, or curd-like discharge

RareFor women who smoke tobacco

• Pains in stomach, side, or abdomen


• yellow eyes or skin

For women with a history of breast disease

• Lumps in breast

• Mental depression


• swelling, pain, or tenderness in upper abdominal area

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Abdominal cramping or bloating


• acne (usually less common after first 3 months and may improve if acne already exists)


• breast pain, tenderness, or swelling


• dizziness


• nausea


• swelling of ankles and feet


• unusual tiredness or weakness


• vomiting

Less common

• Brown, blotchy spots on exposed skin


• gain or loss of body or facial hair


• increased or decreased interest in sexual intercourse


• weight gain or loss

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Ocella side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Ocella resources

• Ocella Side Effects (in more detail)
• Ocella Use in Pregnancy & Breastfeeding
• Drug Images
• Ocella Drug Interactions
• Ocella Support Group
• 51 Reviews for Ocella - Add your own review/rating

• Ocella Prescribing Information (FDA)


• Gianvi Prescribing Information (FDA)


• Loryna Prescribing Information (FDA)


• Syeda Prescribing Information (FDA)


• YAZ MedFacts Consumer Leaflet (Wolters Kluwer)


• Yasmin Prescribing Information (FDA)


• Yasmin Consumer Overview


• Yasmin MedFacts Consumer Leaflet (Wolters Kluwer)


• Yaz Prescribing Information (FDA)


• Yaz Consumer Overview


• Zarah Prescribing Information (FDA)

Compare Ocella with other medications

• Acne
• Birth Control
• Menstrual Disorders
• Premenstrual Dysphoric Disorder

Dekazol

Dekazol may be available in the countries listed below.

Ingredient matches for Dekazol

Miconazole

Miconazole is reported as an ingredient of Dekazol in the following countries:

• Bahrain


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Nigeria


• Oman


• Qatar


• Saudi Arabia


• Sudan


• Syria


• United Arab Emirates


• Yemen

International Drug Name Search

Minsetil

Minsetil may be available in the countries listed below.

Ingredient matches for Minsetil

Mexiletine

Mexiletine hydrochloride (a derivative of Mexiletine) is reported as an ingredient of Minsetil in the following countries:

• Serbia

International Drug Name Search

Pethidin Amino

Pethidin Amino may be available in the countries listed below.

Ingredient matches for Pethidin Amino

Pethidine

Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Pethidin Amino in the following countries:

• Switzerland

International Drug Name Search

Mevlor

Mevlor may be available in the countries listed below.

Ingredient matches for Mevlor

Lovastatin

Lovastatin is reported as an ingredient of Mevlor in the following countries:

• Argentina


• Portugal

International Drug Name Search

Furagins

Furagins may be available in the countries listed below.

Ingredient matches for Furagins

Furazidin

Furazidin is reported as an ingredient of Furagins in the following countries:

• Latvia

International Drug Name Search

Fasigin-N

Fasigin-N may be available in the countries listed below.

Ingredient matches for Fasigin-N

Nystatin

Nystatin is reported as an ingredient of Fasigin-N in the following countries:

• Italy

Tinidazole

Tinidazole is reported as an ingredient of Fasigin-N in the following countries:

• Italy

International Drug Name Search

Vero-Pipecuronium

Vero-Pipecuronium may be available in the countries listed below.

Ingredient matches for Vero-Pipecuronium

Pipecuronium

Pipecuronium Bromide is reported as an ingredient of Vero-Pipecuronium in the following countries:

• Russian Federation

International Drug Name Search

Hosebon

Hosebon may be available in the countries listed below.

Ingredient matches for Hosebon

Danazol

Danazol is reported as an ingredient of Hosebon in the following countries:

• Japan

International Drug Name Search

Ocu-Sul 10

Generic Name: sulfacetamide ophthalmic (SUL fa SEET a mide off THAL mik)

Brand Names: Bleph-10, Ocu-Sul 10, Ocu-Sul 15, Ocu-Sul 30, Sodium Sulamyd, Sulf-10, Sulfac 10%

What is Ocu-Sul 10 (sulfacetamide ophthalmic)?

Sulfacetamide ophthalmic is an antibiotic.

Sulfacetamide ophthalmic is used to treat bacterial infections of the eyes.

Sulfacetamide ophthalmic may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about Ocu-Sul 10 (sulfacetamide ophthalmic)?

Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye.

Apply light pressure to the inside corner of your eye (near your nose) after each drop to prevent the fluid from draining down your tear ducts.

Who should not use Ocu-Sul 10 (sulfacetamide ophthalmic)?

Do not use sulfacetamide ophthalmic if you have a viral or fungal infection in your eye. It is used to treat infections caused by bacteria only.

Do not use sulfacetamide ophthalmic if you have ever had an allergic reaction to a sulfa-based drug.

It is not known whether sulfacetamide ophthalmic will harm an unborn baby. Do not use sulfacetamide ophthalmic without first talking to your doctor if you are pregnant. It is also not known whether sulfacetamide ophthalmic passes into breast milk. Do not use sulfacetamide ophthalmic without first talking to your doctor if you are breast-feeding a baby.

How should I use Ocu-Sul 10 (sulfacetamide ophthalmic)?

Use sulfacetamide ophthalmic eyedrops or ointment exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.

Wash your hands before using your eyedrops or ointment.

To apply the eye drops:

• 
  

  Shake the drops gently to be sure the medicine is well mixed. Tilt your head back slightly and pull down on your lower eyelid. Position the dropper above your eye. Look up and away from the dropper. Squeeze out a drop and close your eye. Apply gentle pressure to the inside corner of your eye (near your nose) for about 1 minute to prevent the liquid from draining down your tear duct. If you are using more than one drop in the same eye or drops in both eyes, repeat the process with about 5 minutes between drops.

  
  

To apply the ointment:

• 
  

  Hold the tube in your hand for a few minutes to warm it up so that the ointment comes out easily. Tilt your head back slightly and pull down gently on your lower eyelid. Apply a thin film of the ointment into your lower eyelid. Close your eye and roll your eyeball around in all directions for 1 to 2 minutes. If you are applying another eye medication, allow at least 10 minutes before the next application.

  
  

Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye. Do not use any eyedrop that is discolored or has particles in it. Store sulfacetamide ophthalmic at room temperature away from moisture and heat. Keep the bottle or tube properly capped.

What happens if I miss a dose?

Apply the missed dose as soon as you remember. However, if it is almost time for your next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.

What happens if I overdose?

An overdose of this medication is unlikely to occur. If you do suspect an overdose, wash the eye with water and call an emergency room or poison control center near you. If the drops or ointment have been ingested, drink plenty of fluid and call an emergency center for advice.

What should I avoid while using Ocu-Sul 10 (sulfacetamide ophthalmic)?

Do not touch the dropper or tube opening to any surface, including your eyes or hands. The dropper or tube opening is sterile. If it becomes contaminated, it could cause an infection in your eye. Use caution when driving, operating machinery, or performing other hazardous activities. Sulfacetamide ophthalmic may cause blurred vision. If you experience blurred vision, avoid these activities.

If you wear contact lenses, ask your doctor if you should wear them during treatment with sulfacetamide ophthalmic. After applying the medication, wait at least 15 minutes before inserting contact lenses, unless otherwise directed by your doctor.

Do not use other eye drops or medications during treatment with sulfacetamide ophthalmic unless otherwise directed by your doctor.

Ocu-Sul 10 (sulfacetamide ophthalmic) side effects

Serious side effects are not expected with this medication.

Commonly, some eye burning, stinging, irritation, itching, redness, blurred vision, eyelid itching, eyelid swelling, or sensitivity to light may occur.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Ocu-Sul 10 (sulfacetamide ophthalmic)?

Do not use this medication with other eyedrops containing nitrates (e.g., silver nitrate).

Do not use other eye drops or medications during treatment with sulfacetamide ophthalmic unless otherwise directed by your doctor.

Drugs other than those listed here may also interact with sulfacetamide ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

More Ocu-Sul 10 resources

• Ocu-Sul 10 Side Effects (in more detail)
• Ocu-Sul 10 Use in Pregnancy & Breastfeeding
• Ocu-Sul 10 Drug Interactions
• Ocu-Sul 10 Support Group
• 0 Reviews for Ocu-Sul0 - Add your own review/rating

• Bleph-10 Drops MedFacts Consumer Leaflet (Wolters Kluwer)


• Bleph-10 Prescribing Information (FDA)


• Isopto Cetamide Prescribing Information (FDA)

Compare Ocu-Sul 10 with other medications

• Conjunctivitis
• Trachoma

Where can I get more information?

• Your pharmacist has additional information about sulfacetamide ophthalmic written for health professionals that you may read.

See also: Ocu-Sul0 side effects (in more detail)

Paracetamol Cinfa

Paracetamol Cinfa may be available in the countries listed below.

Ingredient matches for Paracetamol Cinfa

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Cinfa in the following countries:

• Spain

International Drug Name Search

Macrodantin

In the US, Macrodantin (nitrofurantoin systemic) is a member of the drug class urinary anti-infectives and is used to treat Bladder Infection and Prevention of Bladder infection.

US matches:

• Macrodantin


• Macrodantin Macrocrystalline Capsules

UK matches:

• Macrodantin Capsules 100mg B.P. (SPC)
• Macrodantin Capsules 50mg B.P. (SPC)

Ingredient matches for Macrodantin

Nitrofurantoin

Nitrofurantoin is reported as an ingredient of Macrodantin in the following countries:

• Australia


• Ireland


• Italy


• Malta


• South Africa


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Podophyllotoxine

Podophyllotoxine may be available in the countries listed below.

Ingredient matches for Podophyllotoxine

Podophyllotoxin

Podophyllotoxine (DCF) is also known as Podophyllotoxin (BAN)

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Ocuflox

Ocuflox is a brand name of ofloxacin ophthalmic, approved by the FDA in the following formulation(s):

OCUFLOX (ofloxacin - solution/drops; ophthalmic)

• 
  Manufacturer: ALLERGAN
  
  Approval date: July 30, 1993
  
  Strength(s): 0.3% ^[RLD][AT]

Has a generic version of Ocuflox been approved?

Yes. The following products are equivalent to Ocuflox:

ofloxacin solution/drops; ophthalmic

• 
  Manufacturer: AKORN
  
  Approval date: April 15, 2008
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: ALCON PHARMS LTD
  
  Approval date: May 14, 2004
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: May 14, 2004
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: FDC LTD
  
  Approval date: February 25, 2009
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: FERA PHARMS
  
  Approval date: August 31, 2004
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: HI TECH PHARMA
  
  Approval date: May 14, 2004
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: NOVEX
  
  Approval date: May 14, 2004
  
  Strength(s): 0.3% ^[AT]


• 
  Manufacturer: SANDOZ
  
  Approval date: November 25, 2008
  
  Strength(s): 0.3% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ocuflox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ocuflox.

See also...

• Ocuflox Drops Consumer Information (Wolters Kluwer)
• Ocuflox Consumer Information (Cerner Multum)
• Ocuflox Advanced Consumer Information (Micromedex)
• Ofloxacin Drops Consumer Information (Wolters Kluwer)
• Ofloxacin ophthalmic Consumer Information (Cerner Multum)
• Ophtho-Flox Advanced Consumer Information (Micromedex)
• Ofloxacin Ophthalmic Advanced Consumer Information (Micromedex)
• Ofloxacin eent AHFS DI Monographs (ASHP)

Paracetamol Fecofar

Paracetamol Fecofar may be available in the countries listed below.

Ingredient matches for Paracetamol Fecofar

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Fecofar in the following countries:

• Argentina

International Drug Name Search

Frestol

Frestol may be available in the countries listed below.

Ingredient matches for Frestol

Ketoprofen

Ketoprofen is reported as an ingredient of Frestol in the following countries:

• Japan

International Drug Name Search

Fellfish

Fellfish may be available in the countries listed below.

Ingredient matches for Fellfish

Atenolol

Atenolol is reported as an ingredient of Fellfish in the following countries:

• Japan

International Drug Name Search

Gliclazid KrKa

Gliclazid KrKa may be available in the countries listed below.

Ingredient matches for Gliclazid KrKa

Gliclazide

Gliclazide is reported as an ingredient of Gliclazid KrKa in the following countries:

• Denmark

International Drug Name Search

Magnesium Glycocolle Lafarge

Magnesium Glycocolle Lafarge may be available in the countries listed below.

Ingredient matches for Magnesium Glycocolle Lafarge

Magnesium Gluconate

Magnesium Gluconate is reported as an ingredient of Magnesium Glycocolle Lafarge in the following countries:

• Tunisia

International Drug Name Search

Pazeadin

Pazeadin may be available in the countries listed below.

Ingredient matches for Pazeadin

Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Pazeadin in the following countries:

• Japan

International Drug Name Search

Actastav

Actastav may be available in the countries listed below.

Ingredient matches for Actastav

Stavudine

Stavudine is reported as an ingredient of Actastav in the following countries:

• Russian Federation

International Drug Name Search

Prednison Domesco

Prednison Domesco may be available in the countries listed below.

Ingredient matches for Prednison Domesco

Prednisone

Prednisone is reported as an ingredient of Prednison Domesco in the following countries:

• Vietnam

International Drug Name Search

Omistat

Omistat may be available in the countries listed below.

Ingredient matches for Omistat

Simvastatin

Simvastatin is reported as an ingredient of Omistat in the following countries:

• Italy

International Drug Name Search

Osteofix

Osteofix may be available in the countries listed below.

Ingredient matches for Osteofix

Ipriflavone

Ipriflavone is reported as an ingredient of Osteofix in the following countries:

• Italy

International Drug Name Search

Burgerstein Vitamin E

Burgerstein Vitamin E may be available in the countries listed below.

Ingredient matches for Burgerstein Vitamin E

Tocopherol, α-

Tocopherol, α- is reported as an ingredient of Burgerstein Vitamin E in the following countries:

• Switzerland

International Drug Name Search

Paroxetin Merckle

Paroxetin Merckle may be available in the countries listed below.

Ingredient matches for Paroxetin Merckle

Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetin Merckle in the following countries:

• Austria

International Drug Name Search

Triticum Ac

Triticum Ac may be available in the countries listed below.

Ingredient matches for Triticum Ac

Trazodone

Trazodone hydrochloride (a derivative of Trazodone) is reported as an ingredient of Triticum Ac in the following countries:

• Portugal

International Drug Name Search

Piracetam-neuraxpharm

Piracetam-neuraxpharm may be available in the countries listed below.

Ingredient matches for Piracetam-neuraxpharm

Piracetam

Piracetam is reported as an ingredient of Piracetam-neuraxpharm in the following countries:

• Germany

International Drug Name Search

Proacid

Proacid may be available in the countries listed below.

Ingredient matches for Proacid

Aluminium Glycinate

Aluminium Glycinate is reported as an ingredient of Proacid in the following countries:

• Poland

Magnesium Carbonate

Magnesium Carbonate is reported as an ingredient of Proacid in the following countries:

• Poland

International Drug Name Search

Belmalip

Belmalip may be available in the countries listed below.

Ingredient matches for Belmalip

Simvastatin

Simvastatin is reported as an ingredient of Belmalip in the following countries:

• Spain

International Drug Name Search

Tenoloc

Tenoloc may be available in the countries listed below.

Ingredient matches for Tenoloc

Atenolol

Atenolol is reported as an ingredient of Tenoloc in the following countries:

• Bangladesh

Celiprolol

Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Tenoloc in the following countries:

• Czech Republic


• Slovakia

International Drug Name Search

Prosulf

Prosulf may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

UK matches:

• Prosulf 10mg/ml Solution for Injection (SPC)

Ingredient matches for Prosulf

Protamine

Protamine Sulfate is reported as an ingredient of Prosulf in the following countries:

• Georgia


• Hong Kong


• Israel


• Malta


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Calmagine

Calmagine may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Calmagine

Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Calmagine in the following countries:

• France

International Drug Name Search

Procain Penicillin G Animedica

Procain Penicillin G Animedica may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Procain Penicillin G Animedica

Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Procain Penicillin G Animedica in the following countries:

• Austria

International Drug Name Search

Alusa

Alusa may be available in the countries listed below.

Ingredient matches for Alusa

Aldioxa

Aldioxa is reported as an ingredient of Alusa in the following countries:

• Japan

International Drug Name Search

PCE

Ingredient matches for PCE

Erythromycin

Erythromycin is reported as an ingredient of PCE in the following countries:

• United States

International Drug Name Search

Spal

Spal may be available in the countries listed below.

Ingredient matches for Spal

Sparteine

Sparteine sulfate (a derivative of Sparteine) is reported as an ingredient of Spal in the following countries:

• Taiwan

International Drug Name Search

Folinato de Calcio World Pharma

Folinato de Calcio World Pharma may be available in the countries listed below.

Ingredient matches for Folinato de Calcio World Pharma

Calcium Folinate

Calcium Folinate is reported as an ingredient of Folinato de Calcio World Pharma in the following countries:

• Peru

International Drug Name Search

Glycyol

Glycyol may be available in the countries listed below.

Ingredient matches for Glycyol

Glycyrrhizic Acid

Glycyrrhizic Acid is reported as an ingredient of Glycyol in the following countries:

• Japan

Methionine

Methionine racemate (a derivative of Methionine) is reported as an ingredient of Glycyol in the following countries:

• Japan

International Drug Name Search

Benzoato de bencilo

Benzoato de bencilo may be available in the countries listed below.

Ingredient matches for Benzoato de bencilo

Benzyl Benzoate

Benzyl Benzoate is reported as an ingredient of Benzoato de bencilo in the following countries:

• Colombia


• Peru


• Venezuela

International Drug Name Search

Nycoplus Folsyre

Nycoplus Folsyre may be available in the countries listed below.

Ingredient matches for Nycoplus Folsyre

Folic Acid

Folic Acid is reported as an ingredient of Nycoplus Folsyre in the following countries:

• Norway

International Drug Name Search

Diazomid

Diazomid may be available in the countries listed below.

Ingredient matches for Diazomid

Acetazolamide

Acetazolamide is reported as an ingredient of Diazomid in the following countries:

• Turkey

International Drug Name Search

Fenofibrato Ranbaxy

Fenofibrato Ranbaxy may be available in the countries listed below.

Ingredient matches for Fenofibrato Ranbaxy

Fenofibrate

Fenofibrate is reported as an ingredient of Fenofibrato Ranbaxy in the following countries:

• Spain

International Drug Name Search

Glimépiride Ratiopharm

Glimépiride Ratiopharm may be available in the countries listed below.

Ingredient matches for Glimépiride Ratiopharm

Glimepiride

Glimepiride is reported as an ingredient of Glimépiride Ratiopharm in the following countries:

• France

International Drug Name Search

Clinacnyl

Clinacnyl may be available in the countries listed below.

Ingredient matches for Clinacnyl

Clindamycin

Clindamycin is reported as an ingredient of Clinacnyl in the following countries:

• Chile

International Drug Name Search

Perdofemina

Perdofemina may be available in the countries listed below.

Ingredient matches for Perdofemina

Ibuprofen

Ibuprofen lysine (a derivative of Ibuprofen) is reported as an ingredient of Perdofemina in the following countries:

• Belgium


• Luxembourg

International Drug Name Search

Paroxetina Generis

Paroxetina Generis may be available in the countries listed below.

Ingredient matches for Paroxetina Generis

Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetina Generis in the following countries:

• Portugal

International Drug Name Search

Magnecyl brus

Magnecyl brus may be available in the countries listed below.

Ingredient matches for Magnecyl brus

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Magnecyl brus in the following countries:

• Sweden

International Drug Name Search

Zolpidem-CT

Zolpidem-CT may be available in the countries listed below.

Ingredient matches for Zolpidem-CT

Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem-CT in the following countries:

• Germany

International Drug Name Search

Enteraproct

Enteraproct may be available in the countries listed below.

Ingredient matches for Enteraproct

Mesalazine

Mesalazine is reported as an ingredient of Enteraproct in the following countries:

• Italy

International Drug Name Search

Pentoxifyllin Basics

Pentoxifyllin Basics may be available in the countries listed below.

Ingredient matches for Pentoxifyllin Basics

Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentoxifyllin Basics in the following countries:

• Germany

International Drug Name Search

Bronchostop

Bronchostop may be available in the countries listed below.

Ingredient matches for Bronchostop

Guaifenesin

Guaifenesin is reported as an ingredient of Bronchostop in the following countries:

• Austria

International Drug Name Search

Paracetamol Generis

Paracetamol Generis may be available in the countries listed below.

Ingredient matches for Paracetamol Generis

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Generis in the following countries:

• Portugal

International Drug Name Search

Liposcler

Liposcler may be available in the countries listed below.

Ingredient matches for Liposcler

Lovastatin

Lovastatin is reported as an ingredient of Liposcler in the following countries:

• Spain

International Drug Name Search

Cefthan

Cefthan may be available in the countries listed below.

Ingredient matches for Cefthan

Cefroxadine

Cefroxadine is reported as an ingredient of Cefthan in the following countries:

• Japan

International Drug Name Search

Losec

Losec may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

UK matches:

• Losec Capsules 10mg, 20mg,40mg
• Losec I.V. Injection 40mg
• Losec Infusion 40mg
• Losec MUPS Tablets 10mg, 20mg, 40mg
• Losec Capsules 10mg, 20mg & 40mg (SPC)
• Losec I.V. Injection 40mg (SPC)
• Losec IV Injection Solvent (SPC)
• Losec MUPS Tablets 10mg, 20mg & 40mg (SPC)

Ingredient matches for Losec

Omeprazole

Omeprazole is reported as an ingredient of Losec in the following countries:

• Austria


• Bahrain


• Canada


• Cyprus


• Czech Republic


• Denmark


• Estonia


• Ethiopia


• Georgia


• Ghana


• Guyana


• Hungary


• India


• Indonesia


• Iraq


• Ireland


• Israel


• Italy


• Kenya


• Kuwait


• Lebanon


• Libya


• Luxembourg


• Malawi


• Malaysia


• Mozambique


• New Zealand


• Nigeria


• Oman


• Peru


• Philippines


• Poland


• Qatar


• Romania


• Saudi Arabia


• Serbia


• Slovakia


• South Africa


• Sudan


• Taiwan


• Tanzania


• Turkey


• Uganda


• United Arab Emirates


• United Kingdom


• Vietnam


• Yemen


• Zambia


• Zimbabwe

Omeprazole magnesium salt (a derivative of Omeprazole) is reported as an ingredient of Losec in the following countries:

• Australia


• Canada


• Netherlands


• Spain


• Sweden

Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Losec in the following countries:

• Austria


• Belgium


• Brazil


• Chile


• China


• Czech Republic


• Denmark


• Ecuador


• Estonia


• Finland


• Greece


• Iceland


• Ireland


• Italy


• Latvia


• Mexico


• Netherlands


• New Zealand


• Norway


• Portugal


• Singapore


• Slovakia


• Spain


• Sweden


• Thailand


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Trebianom

Trebianom may be available in the countries listed below.

Ingredient matches for Trebianom

Benzbromarone

Benzbromarone is reported as an ingredient of Trebianom in the following countries:

• Japan

International Drug Name Search

Dioxaflex Parches

Dioxaflex Parches may be available in the countries listed below.

Ingredient matches for Dioxaflex Parches

Diclofenac

Diclofenac hydroxyethylpyrrolidine (a derivative of Diclofenac) is reported as an ingredient of Dioxaflex Parches in the following countries:

• Colombia


• Dominican Republic


• El Salvador

International Drug Name Search

Oxacillin

In some countries, this medicine may only be approved for veterinary use.

In the US, Oxacillin (oxacillin systemic) is a member of the drug class penicillinase resistant penicillins and is used to treat Bacterial Infection, Bone infection, Endocarditis, Joint Infection, Meningitis, Pneumonia, Septicemia, Sinusitis and Skin Infection.

US matches:

• Oxacillin


• Oxacillin Solution


• Oxacillin Sodium


• Oxacillin Injection

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01CF04

CAS registry number (Chemical Abstracts Service)

0000066-79-5

Chemical Formula

C19-H19-N3-O5-S

Molecular Weight

401

Therapeutic Category

Antibacterial: Penicillin, penicillinase-resistant

Chemical Name

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, [2S-(2α,5α,6ß)]-

Foreign Names

• Oxacillinum (Latin)
• Oxacillin (German)
• Oxacilline (French)
• Oxacilina (Spanish)

Generic Names

• Oxacillin (OS: BAN)
• Oxacillina (OS: DCIT)
• Oxacilline (OS: DCF)
• AB 1400 (IS)
• BRL 1400 (IS)
• Oxazocilline (IS: DCF vieille)
• Oxacillin Sodium (OS: USAN)
• P 12 (IS)
• SQ 16423 (IS)
• Oxacillin Sodium (PH: USP 32)
• Oxacillin Sodium Monohydrate (PH: BP 2010, Ph. Eur. 6)
• Oxacillinum natricum monohydricum (PH: Ph. Eur. 6)

Brand Names

• Bicillin-3
  Arterium, Georgia



• Bicillin-5
  Arterium, Georgia



• Bristopen
  Bristol-Myers Squibb, Tunisia



• Dicloxal Ox
  Magma, Peru



• Oxacil
  Unimed, Tunisia



• Oxacilinã Forte
  Lek, Romania; Mark, Romania



• Oxacilina La Santé
  La Santé, Colombia



• Oxacilina
  AZ Pharma, Colombia; Blaskov, Colombia; Farmionni, Colombia; Vitalis, Venezuela



• Oxacilline Sodique
  Antiobiotice, Tunisia



• Oxagram
  Medicef, Tunisia



• Oxalin
  Europharm, Romania



• Oxapen
  Saiph, Tunisia



• Pan-Oxacillin
  Panpharma, Lithuania



• Stapenor Retard Salbe (Oxacillin and Oxacillin (veterinary use))
  Bayer Animal, Germany



• Bactocill
  GlaxoSmithKline Pharm., United States



• Biocilina
  Biogalenic, Venezuela



• Bristopen
  Bristol-Myers Squibb, Burkina Faso; Bristol-Myers Squibb, Burundi; Bristol-Myers Squibb, Benin; Bristol-Myers Squibb, Central African Republic; Bristol-Myers Squibb, Congo; Bristol-Myers Squibb, Cote D'ivoire; Bristol-Myers Squibb, Cameroon; Bristol-Myers Squibb, Algeria; Bristol-Myers Squibb, France; Bristol-Myers Squibb, Gabon; Bristol-Myers Squibb, Guinea; Bristol-Myers Squibb, Madagascar; Bristol-Myers Squibb, Mali; Bristol-Myers Squibb, Mauritania; Bristol-Myers Squibb, Mauritius; Bristol-Myers Squibb, Niger; Bristol-Myers Squibb, Senegal; Bristol-Myers Squibb, Chad; Bristol-Myers Squibb, Togo; Bristol-Myers Squibb, Zaire



• Dicloxal
  Magma, Peru



• InfectoStaph
  Infectopharm, Germany



• Masteet (veterinary use)
  Ceva, Germany



• Oxacilin Leciva
  Zentiva, Czech Republic; Zentiva, Slovakia



• Oxacilina
  Britania, Peru; Farmo Andina, Peru; Flupal, Venezuela; Genéricos Venezolanos, Venezuela; Proula, Venezuela; Vitalis, Peru



• Oxacilinã
  Antibiotice, Romania; Arena, Romania; Europharm, Romania; Farmex, Romania; Lek, Romania; Ozone Laboratories, Romania



• Oxacillin Sodium
  Baxter, United States; Marsam, United States; Sandoz, United States



• Oxacillin (veterinary use)
  CP-Pharma, Germany; Riemser Animal, Germany; Veyx, Germany



• Oxacilline Panpharma
  Panpharma, France



• Oxamicin
  Ronava, Venezuela



• Oxipen
  Behrens, Venezuela



• Pan-Oxacillin
  Panpharma, Latvia



• Penstapho
  Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Luxembourg



• Prostafilina
  Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Venezuela



• Prostaphlin
  Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Estonia; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Taiwan



• Staficilin-N
  Bristol-Myers Squibb, Brazil



• Stapenor (veterinary use)
  Bayer Animal, Germany; Bayer Sanità Animale, Italy



• Stapenor Retard Salbe (Oxacillin and Oxacillin (veterinary use))
  Bayer Animal, Germany

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Maprolu

Maprolu may be available in the countries listed below.

Ingredient matches for Maprolu

Maprotiline

Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Maprolu in the following countries:

• Germany


• Luxembourg

Maprotiline mesilate (a derivative of Maprotiline) is reported as an ingredient of Maprolu in the following countries:

• Germany

International Drug Name Search

Cefpiran

Cefpiran may be available in the countries listed below.

Ingredient matches for Cefpiran

Ceftazidime

Ceftazidime is reported as an ingredient of Cefpiran in the following countries:

• Peru

International Drug Name Search

Entocort Enema

Entocort Enema may be available in the countries listed below.

Ingredient matches for Entocort Enema

Budesonide

Budesonide is reported as an ingredient of Entocort Enema in the following countries:

• Brazil


• Luxembourg


• Spain


• Switzerland

International Drug Name Search

Ulcodyn

Ulcodyn may be available in the countries listed below.

Ingredient matches for Ulcodyn

Ranitidine

Ranitidine is reported as an ingredient of Ulcodyn in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Paracetamol Therapeuticon

Paracetamol Therapeuticon may be available in the countries listed below.

Ingredient matches for Paracetamol Therapeuticon

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Therapeuticon in the following countries:

• Netherlands

International Drug Name Search

Tamoxifen CF

Tamoxifen CF may be available in the countries listed below.

Ingredient matches for Tamoxifen CF

Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifen CF in the following countries:

• Netherlands

International Drug Name Search

Paroxetina Tarbis

Paroxetina Tarbis may be available in the countries listed below.

Ingredient matches for Paroxetina Tarbis

Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetina Tarbis in the following countries:

• Spain

International Drug Name Search

Gazim

Gazim may be available in the countries listed below.

Ingredient matches for Gazim

Simeticone

Simeticone is reported as an ingredient of Gazim in the following countries:

• Israel

International Drug Name Search

Wiacid

Wiacid may be available in the countries listed below.

Ingredient matches for Wiacid

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Wiacid in the following countries:

• Indonesia

International Drug Name Search

Furoser

Furoser may be available in the countries listed below.

Ingredient matches for Furoser

Furosemide

Furosemide is reported as an ingredient of Furoser in the following countries:

• Bulgaria

International Drug Name Search

Bronconox

Bronconox may be available in the countries listed below.

Ingredient matches for Bronconox

Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Bronconox in the following countries:

• Colombia

International Drug Name Search

PMS-Amantadine HCL

PMS-Amantadine HCL may be available in the countries listed below.

Ingredient matches for PMS-Amantadine HCL

Amantadine

Amantadine hydrochloride (a derivative of Amantadine) is reported as an ingredient of PMS-Amantadine HCL in the following countries:

• Singapore

International Drug Name Search

Acyflox

Acyflox may be available in the countries listed below.

Ingredient matches for Acyflox

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Acyflox in the following countries:

• Spain

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Acyflox in the following countries:

• Spain

International Drug Name Search

Valturna

Valturna is a brand name of aliskiren/valsartan, approved by the FDA in the following formulation(s):

VALTURNA (aliskiren hemifumarate; valsartan - tablet; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: September 16, 2009
  
  Strength(s): EQ 150MG BASE;160MG, EQ 300MG BASE;320MG ^[RLD]

Has a generic version of Valturna been approved?

No. There is currently no therapeutically equivalent version of Valturna available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Valturna. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Acyl compounds
  Patent 5,399,578
  Issued: March 21, 1995
  Inventor(s): Buhlmayer; Peter & Ostermayer; Franz & Schmidlin; Tibur
  Assignee(s): Ciba-Geigy Corp
  Compounds of the formula ##STR1## in which R.sub.1 is an aliphatic hydrocarbon radical which is unsubstituted or substituted by halogen or hydroxyl, or a cycloaliphatic or araliphatic hydrocarbon radical; X.sub.1 is CO, SO.sub.2, or --O--C(.dbd.O)-- with the carbon atom of the carbonyl group being attached to the nitrogen atom shown in formula I; X.sub.2 is a divalent aliphatic hydrocarbon radical which is unsubstituted or substituted by hydroxyl, carboxyl, amino, guanidino or a cycloaliphatic or aromatic radical, or is a divalent cycloaliphatic hydrocarbon radical, it being possible for a carbon atom of the aliphatic hydrocarbon radical to be additionally bridged by a divalent aliphatic hydrocarbon radical; R.sub.2 is carboxyl which, if desired, is esterified or amidated, substituted or unsubstituted amino, formyl which, if desired, is acetalized, 1H-tetrazol-5-yl, pyridyl, hydroxyl which, if desired, is etherified, S(O).sub.m --R where m is 0, 1 or 2 and R is hydrogen or an aliphatic hydrocarbon radical, alkanoyl, unsubstituted or N-substituted sulfamoyl or PO.sub.n H.sub.2 where n is 2 or 3; X.sub.3 is a divalent aliphatic hydrocarbon; R.sub.3 is carboxyl, 5-tetrazolyl, SO.sub.3 H, PO.sub.2 H.sub.2, PO.sub.3 H.sub.2 or haloalkylsulfamoyl; and the rings A and B independently of one another are substituted or unsubstituted; in free form or in salt form, can be prepared in a manner known per se and can be used, for example, as medicament active ingredients.
  
  Patent expiration dates:
  
  
  • March 21, 2012
    
    ✓ 
    Patent use: TREATMENT OF HYPERTENSION
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  .delta.-amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides
  Patent 5,559,111
  Issued: September 24, 1996
  Inventor(s): G oschke; Richard & Maibaum; J urgen K. & Schilling; Walter & Stutz; Stefan & Rigollier; Pascal & Yamaguchi; Yasuchika & Cohen; Nissim C. & Herold; Peter
  Assignee(s): Ciba-Geigy Corporation
  .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients.
  
  Patent expiration dates:
  
  
  • July 21, 2018
    
    ✓ 
    Patent use: TREATMENT OF HYPERTENSION
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • March 5, 2012 - NEW CHEMICAL ENTITY
  
  
  • September 16, 2012 - NEW COMBINATION
  
  

See also...

• Valturna Consumer Information (Drugs.com)
• Valturna Consumer Information (Wolters Kluwer)
• Valturna Consumer Information (Cerner Multum)
• Valturna Advanced Consumer Information (Micromedex)
• Aliskiren/Valsartan Consumer Information (Wolters Kluwer)
• Aliskiren and valsartan Consumer Information (Cerner Multum)
• Aliskiren and valsartan Advanced Consumer Information (Micromedex)